---
title: "Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 — Data Talk"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292670195.md"
description: "Bristol-Myers Squibb (BMY) is on pace for its largest percentage decrease since November 2025, currently trading at $56.94, down 4.05%. This marks the lowest close since July 2026 and follows three down days in the past five. While up 5.55% year-to-date, the stock remains down nearly 30% from its all-time high."
datetime: "2026-07-14T20:06:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292670195.md)
  - [en](https://longbridge.com/en/news/292670195.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292670195.md)
---

# Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 — Data Talk

Bristol-Myers Squibb Company (BMY) is currently at $56.94, down $2.41 or 4.05%

\--Would be lowest close since July 6, 2026, when it closed at $56.70

\--On pace for largest percent decrease since Nov. 14, 2025, when it fell 4.07%

\--Currently down three of the past five days

\--Down 1.19% month-to-date

\--Up 5.55% year-to-date

\--Down 29.82% from its all-time closing high of $81.13 on Dec. 2, 2022

\--Up 22.63% from 52 weeks ago (July 15, 2025), when it closed at $46.43

\--Down 8.71% from its 52-week closing high of $62.37 on Feb. 27, 2026

\--Up 33.65% from its 52-week closing low of $42.60 on Oct. 29, 2025

\--Traded as low as $56.83; lowest intraday level since July 6, 2026, when it hit $56.49

\--Down 4.23% at today's intraday low; largest intraday percent decrease since June 1, 2026, when it fell as much as 4.33%

All data as of 3:44:56 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 14, 2026 16:03 ET (20:03 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory](https://longbridge.com/en/news/293326979.md)
- [Bristol Myers Squibb Company $BMY Stake Raised by Sei Investments Co.](https://longbridge.com/en/news/293735773.md)
- [Final trade: KBE, BMY, SMH, LMT](https://longbridge.com/en/news/293673640.md)
- [Calidi Biotherapeutics adds former Genentech, Celgene executive Corsee Sanders to board](https://longbridge.com/en/news/293337933.md)
- [FDA accepts Bristol Myers NDA for mezigdomide in multiple myeloma, sets May 13, 2027 decision date](https://longbridge.com/en/news/292477087.md)